Search Results

Ascensia Diabetes Care, a global diabetes care company, makers of CONTOUR® blood glucose monitoring system portfolio and distributors of the Eversense® continuous glucose monitoring system, was named as an honoree at the Joslin Diabetes Center High Hopes Gala, to celebrate the 100th Anniversary of Insulin, held on November 13th.

In a paper published in Science Translational Medicine, researchers from City of Hope®, one of the largest cancer research and treatment organizations in the United States and a leading research center for diabetes and other life-threatening illnesses, report that they have discovered advances in predicting kidney failure in type 1 diabetes patients.

Roughly 11 percent of people living in the United States have type 2 diabetes and nearly 40 percent of adults have prediabetes, according to the Centers for Disease Control and Prevention.

Joslin Diabetes Center is providing notice of a cyber incident that may affect the security of some information relating to certain individuals associated with Joslin, including donors and patients.

Kubota Vision Inc., a clinical-stage specialty ophthalmology company and a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd., announced that the Company and Joslin Diabetes Center have entered into a material transfer and collaboration agreement for our Patient Based Ophthalmology Suite, in-home optical coherence tomography device.